Artículos de revistas
Weight Variation In Users Of Depot-medroxyprogesterone Acetate, The Levonorgestrel-releasing Intrauterine System And A Copper Intrauterine Device For Up To Ten Years Of Use
Registro en:
European Journal Of Contraception And Reproductive Health Care. Informa Healthcare, v. 20, n. 1, p. 57 - 63, 2015.
13625187
10.3109/13625187.2014.951433
2-s2.0-84921908588
Autor
Modesto W.
De Nazare Silva Dos Santos P.
Correia V.M.
Borges L.
Bahamondes L.
Institución
Resumen
Background and objective Data on record regarding weight variation in depot-medroxyprogesterone acetate (DMPA) and levonorgestrel-releasing intrauterine system (LNG-IUS) users are controversial. To date, no studies have yet evaluated weight variation in DMPA and LNG-IUS users in up to ten years of use compared to non-hormonal contraceptive users. Materials and methods A retrospective study analysed weight variations in 2138 women using uninterruptedly DMPA (150 mg intramuscularly, three-monthly; n = 714), the LNG-IUS (n = 701) or a copper-intrauterine device (Cu-IUD; n = 723). Results At the end of the first year of use, there was a mean weight increase of 1.3 kg, 0.7 kg and 0.2 kg among the DMPA-, LNG-IUS- and Cu-IUD users, respectively, compared to weight at baseline (p < 0.0001). After ten years of use, the mean weight had risen by 6.6 kg, 4.0 and 4.9 kg among the DMPA-, LNG-IUS- and Cu-IUD users, respectively. DMPA-users had gained more weight than LNG-IUS- (p = 0.0197) and than Cu-IUD users (p = 0.0294), with the latter two groups not differing significantly from each other in this respect (p = 0.5532). Conclusion Users of hormonal and non-hormonal contraceptive methods gained a significant amount of weight over the years. DMPA users gained more weight over the treatment period of up to ten years than women fitted with either a LNG-IUS or a Cu-IUD. 20 1 57 63 Caballero, B., The global epidemic of obesity: An overview (2007) Epidemiol Rev, 29, pp. 1-5 May, A.M., Romaguera, D., Travier, N., Combined impact of lifestyle factors on prospective change in body weight and waist circumference in participants of the EPIC-PANACEA study (2012) PLoS One, 7, p. e50712 Lopez, L.M., Edelman, A., Chen, M., Progestin-only contraceptives: Effects on weight (2013) Cochrane Database Syst Rev, 2, p. 7 Le, Y.C., Rahman, M., Berenson, A.B., Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users (2009) Obstet Gynecol, 114, pp. 279-284 Said, S., Omar, K., Koetsawang, S., A multicentred phase III comparative trial of depo-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg. 1. Contraceptive effi cacy and side effects (1986) World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, 34, pp. 223-235. , Special Programme of Research, Development and Research Training in Human Reproduction. Contraception Vickery, Z., Madden, T., Zhao, Q., Weight change at 12 months in users of three progestin-only contraceptive methods (2013) Contraception, 88, pp. 503-508 Nault, A.M., Peipert, J.F., Zhao, Q., Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate (2013) Am J Obstet Gynecol, 208, pp. 1-8 Hassan, D.F., Petta, C.A., Aldrighi, J.M., Weight variation in a cohort of women using copper IUD for contraception (2003) Contraception, 68, pp. 27-30 Bahamondes, L., Del, C.S., Tabares, G., Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years (2001) Contraception, 64, pp. 223-225 Yela, D.A., Monteiro, I.M., Bahamondes, L.G., Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil (2006) Rev Assoc Med Bras, 521, pp. 32-36 Pantoja, M., Medeiros, T., Baccarin, M.C., Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive (2010) Contraception, 81, pp. 107-111 Baldaszti, E., Wimmer-Puchinger, B., Lö Schke, K., Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): A 3-year follow-up study (2003) Contraception, 67, pp. 87-91 Sheng, J., Zhang, W.Y., Zhang, J.P., The LNG-IUS study on adenomyosis: A 3-year follow-up study on the effi cacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis (2009) Contraception, 79, pp. 189-193 Peipert, J.F., Zhao, Q., Allsworth, J.E., Continuation and satisfaction of reversible contraception (2011) Obstet Gynecol, 117, pp. 1105-1113 Suhonen, S., Haukkamaa, M., Jakobsson, T., Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: A comparative study (2004) Contraception, 69, pp. 407-412 Dal'ava, N., Bahamondes, L., Bahamondes, M.V., Body weight and composition in users of levonorgestrel-releasing intrauterine system (2012) Contraception, 86, pp. 350-353 Winner, B., Peipert, J.F., Zhao, Q., Effectiveness of long-acting reversible contraception (2012) N Engl J Med, 366, pp. 1998-2007 Clark, M.K., Dillon, J.S., Sowers, M., Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception (2005) Int J Obes (Lond), 29, pp. 1252-1258 Berenson, A.B., Rahman, M., Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use (2009) Am J Obstet Gynecol, 200, pp. 329e1-8 Modesto, W., Ahamondes M, B., V., Ilva Dos Santos P, S., Exploratory study of the effect of lifestyle counselling on bone mineral density and body composition in users of the contraceptive depot-medroxyprogesterone acetate (2014) Eur J Contracept Reprod Health Care, 19, pp. 244-249 M inisté r io da Saú de, Secretaria de Vigilâ ncia em Saú de: Vigitel Brasil 2011: Vigil â ncia de Fatores de Risco e Prote ç ã o para Doen ç as Cr ô nicas por Inqu é rito Telef ô nico (S é rie G Estat í stica e Informa ç ã o em Sa ú de). Bras í lia, 2012Rennie, K.L., Jebb, S.A., Prevalence of obesity in Great Britain (2005) Obes Rev, 6, pp. 11-12 (2012) Prevalence of Obesity in the United States, 2009-2010, , NCHS 2 012 National Health and Nutrition Examination Survey (NCHS) Data Brief. No 82, NCHS Pelkman, C., Hormones and weight change (2002) J Reprod Med, 47, pp. 791-794